VAXART INC. - COMMON

0.6100

27-November-24 15:45:00

15 minutes delayed

Stocks

+0.0108

+1.80%

Today's range

0.5970 - 0.6300

ISIN

N/A

Source

NASDAQ

Poll: Oral Covid-19 Vaccine Pill Offers a Way to Overcome Vaccine Resistance of Millions of Americans

22 Apr 2021 07:00:03 By Nasdaq GlobeNewswire
Vaxart to Present at the H.C. Wainwright Global Life Sciences Conference

04 Mar 2021 15:01:00 By Nasdaq GlobeNewswire
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

25 Feb 2021 15:01:01 By Nasdaq GlobeNewswire
Vaxart to Provide 2021 Business Outlook on Tuesday, March 2, 2021

24 Feb 2021 15:01:00 By Nasdaq GlobeNewswire
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

03 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Vaxart Announces Publication of a Peer-reviewed Journal Article Showing the Potential Clinical and Economic Value of a Norovirus Vaccine

27 Jan 2021 07:30:00 By Nasdaq GlobeNewswire
Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication

26 Jan 2021 07:30:01 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.